Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 138911000087117 | HepaGam B 312 international units per milliliter liquid for injection Cangene Corporation (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 25001000087115 | HBIg HepaGam B Cang | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 25021000087114 | HepaGam B 312 international units per milliliter liquid for injection Cangene Corporation | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 74211000087110 | HBIg HepaGam B Cang | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway French module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| HepaGam B 312 international units per milliliter liquid for injection Cangene Corporation (real clinical drug) | a une forme pharmaceutique (attribut) | solution pour injection (forme pharmaceutique) | true | Inferred relationship | Some | ||
| HepaGam B 312 international units per milliliter liquid for injection Cangene Corporation (real clinical drug) | Has concentration strength numerator unit | Unit | true | Inferred relationship | Some | 1 | |
| HepaGam B 312 international units per milliliter liquid for injection Cangene Corporation (real clinical drug) | Has precise active ingredient | Hepatitis B immunoglobulin | true | Inferred relationship | Some | 1 | |
| HepaGam B 312 international units per milliliter liquid for injection Cangene Corporation (real clinical drug) | Has supplier | Cangene Corporation (supplier) | true | Inferred relationship | Some | ||
| HepaGam B 312 international units per milliliter liquid for injection Cangene Corporation (real clinical drug) | Has concentration strength numerator value (attribute) | 312 (qualifier value) | false | Inferred relationship | Some | 1 | |
| HepaGam B 312 international units per milliliter liquid for injection Cangene Corporation (real clinical drug) | Plays role | Passive immunity stimulant therapeutic role | true | Inferred relationship | Some | ||
| HepaGam B 312 international units per milliliter liquid for injection Cangene Corporation (real clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Some | 1 | |
| HepaGam B 312 international units per milliliter liquid for injection Cangene Corporation (real clinical drug) | est un(e) (attribut) | Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection | true | Inferred relationship | Some | ||
| HepaGam B 312 international units per milliliter liquid for injection Cangene Corporation (real clinical drug) | Has concentration strength denominator unit | Milliliter (qualifier value) | true | Inferred relationship | Some | 1 | |
| HepaGam B 312 international units per milliliter liquid for injection Cangene Corporation (real clinical drug) | Has basis of strength substance (attribute) | Hepatitis B immunoglobulin | true | Inferred relationship | Some | 1 | |
| HepaGam B 312 international units per milliliter liquid for injection Cangene Corporation (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| HepaGam B 312 international units per milliliter liquid for injection Cangene Corporation (real clinical drug) | est un(e) (attribut) | HBIg hepatitis B immunoglobulin unspecified | false | Inferred relationship | Some | ||
| HepaGam B 312 international units per milliliter liquid for injection Cangene Corporation (real clinical drug) | a pour principe actif (attribut) | Hepatitis B immunoglobulin | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Historical name codes for passive immunizing agents reference set (foundation metadata concept)
FHIR